Amarin Corp Plc (AMRN)

[amarininvestor]

VuBRU,

I don't fully understand the data on table 3 from today's presentation (https://www.acc.org/~/media/Clinical/PDF-Files/Approved-PDFs/2019/11/11/AHA19/Nov18-Mon/9am-EVAPORATE-aha-2019.pdf)

However, it seems to me that low attenuation plaque is just a small fraction of the total plaque, so variability overthrew (due to the low relative volume) may explain that the p value is high.

Now when you look at total plaque, obviously the numbers are much higher....and potentially more reliable for the mechanism?

I would appreciate your thoughts on the numbers on table-3....thanks so much for all your great contributions